Learn more

MERCK SANTE SAS

Overview
  • Total Patents
    73
About

MERCK SANTE SAS has a total of 73 patent applications. Its first patent ever was published in 1998. It filed its patents most often in France, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are DEL SOLDATO PIERO, CUENOUD BERNARD and EUTHYMICS BIOSCIENCE INC.

Patent filings per year

Chart showing MERCK SANTE SASs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Moinet Gerard 16
#2 Bonhomme Yves 15
#3 Mesangeau Didier 13
#4 Kergoat Micheline 13
#5 Cravo Daniel 13
#6 Doare Liliane 11
#7 Nicholson Geoffrey 9
#8 Nicholson Sarah J 9
#9 Cave Gillian 7
#10 Roche Didier 6

Latest patents

Publication Filing date Title
EP2110374A1 Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
EP2058308A1 Benzimidazoledihydrothiadiazinone derivatives used as fructose-1,6-biphosphatase inhibitors and pharmaceutical compositions containing same.
EP1935420A1 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors
EP1918285A1 Diazepane-acetamide derivatives as selective 11beta-HSD1 inhibitors
EP1801098A1 2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
EP1754483A1 Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
EP1752450A1 Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
EP1609786A1 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids
EP1600446A1 New 3,3-dimethyl-5-cyano-benzoxepine derivatives useful for the preparation of 5-formyl-benzoxepine derivatives
EP1591434A1 New 1-methoxy-2-phenyl ethenes useful for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines
FR2865733A1 Thiazolylimidazole derivatives, processes for their preparation, pharmaceutical compositions containing them and medicine applications thereof
FR2864535A1 Quinoline acid derivatives and their therapeutic applications
FR2849598A1 Use of kynurenine-3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of cells of the langerhans islands
EP1535612A1 Treatment for hyperuricemia
FR2862966A1 Nitroso derivatives of diphenylamine.
FR2862964A1 Derivatives of diphenylamine.
FR2862965A1 Novel phenoxyacetamide derivatives and their use for the preparation of diphenylamides.
FR2862646A1 Novel antidiabetic compounds containing benzofuran, benzothiophenic derivatives
FR2862645A1 Antidiabetic compounds containing benzofuran, benzothiophenic derivatives
FR2859220A1 Promoter of fatp 5 human gene and uses thereof